The seca mBCA 515 marks a milestone in the further development of bioimpedance analysis for medical use. After more than ten successful years, we are now saying goodbye to our first body composition analyzer. It is no longer available.
Its successor is the seca mBCA 555, which determines body composition on the basis of the same validation data as the seca mBCA 515. In addition to medically validated precision, it scores with innovative functions, including cloud-based analysis software and a patient app.